skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > ureas > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
organic heterocyclic compound > organosulfur heterocyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organooxygen compound > carbonyl compound > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organooxygen compound > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > hydroxides > oxoacid > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > main group molecular entity > s-block molecular entity > hydrogen molecular entity > hydroxides > oxoacid > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide

اصطلاح مرجح

n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C44H78N6O20S

اینچی

  • InChI=1S/C44H78N6O20S/c1-27(53)47-36-39(58)38(57)30(24-51)68-43(36)70-41-31(25-52)69-42(37(40(41)59)48-28(2)54)67-11-5-9-45-34(56)8-12-61-14-16-63-18-20-65-22-23-66-21-19-64-17-15-62-13-10-46-33(55)7-4-3-6-32-35-29(26-71-32)49-44(60)50-35/h29-32,35-43,51-52,57-59H,3-26H2,1-2H3,(H,45,56)(H,46,55)(H,47,53)(H,48,54)(H2,49,50,60)/t29-,30+,31+,32-,35-,36+,37+,38-,39+,40+,41-,42-,43+/m0/s1

اینچی‌کی

  • CJTYFHCGCIBPHA-GFVBJPICSA-N

جرم

  • 1043.190

جرم تک‌ایزوتوپی

  • 1042.49916

اسمایلٓ

  • [C@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)NC(C)=O)O[C@@H]2[C@@H]([C@H]([C@H](O[C@@H]2CO)OCCCNC(CCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H]3[C@]4(NC(N[C@]4(CS3)[H])=O)[H])=O)=O)NC(C)=O)O

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • N-(3-{[2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]oxy}propyl)-23-oxo-27-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19-hexaoxa-22-azaheptacosan-1-amide

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:146269

این مفهوم را بارگیری کن: